Boune S, Hu P, Epstein AL, Khawli LA. Principles of N-linked glycosylation variations of IgG-based therapeutics: pharmacokinetic and functional considerations. Antibodies. 2020;9(2):22
Jennewein MF, Alter G. The immunoregulatory roles of antibody glycosylation. Trends Immunol. 2017;38(5):358–72.
Shkunnikova S, Mijakovac A, Sironic L, Hanic M, Lauc G, Kavur MM. IgG glycans in health and disease: prediction, intervention, prognosis, and therapy. Biotechnol Adv. 2023;67:108169.
Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo J, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, Lazar J, Fischl MA, Haberlen S, Macatangay B, Adimora AA, Jamieson BD, Rinaldo C, Merenstein D, Roan NR, Kutsch O, Gange S, Wolinsky SM, Witt MD, Post WS, Kossenkov A, Landay AL, Frank I, Tien PC, Gross R, Brown TT, Abdel-Mohsen M. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection. Nat Commun. 2024;15(1):3035.
CAS PubMed PubMed Central Google Scholar
Kanto N, Ohkawa Y, Kitano M, Maeda K, Shiida M, Ono T, Ota F, Kizuka Y, Kunimasa K, Nishino K, Mukai M, Seike M, Azuma A, Harada Y, Fukuda T, Gu J, Taniguchi N. A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2. J Biol Chem. 2023;299(12):105365.
CAS PubMed PubMed Central Google Scholar
Zhang ZJ, Liu C, Ma JL, Ma JS, Wang J, Li RN, Lu D, Zhou YP, Lian TY, Zhang SJ, Li JH, Wang L, Sun K, Cheng CY, Wu WH, Jiang X, Jing ZC. Prognostic value of plasma immunoglobulin G N-glycome traits in pulmonary arterial hypertension. J Am Coll Cardiol. 2024;84(12):1092–103.
Gaifem J, Rodrigues CS, Petralia F, Alves I, Leite-Gomes E, Cavadas B, Dias AM, Moreira-Barbosa C, Revés J, Laird RM, Novokmet M, Štambuk J, Habazin S, Turhan B, Gümüş ZH, Ungaro R, Torres J, Lauc G, Colombel JF, Porter CK, Pinho SS. A unique serum IgG glycosylation signature predicts development of Crohn’s disease and is associated with pathogenic antibodies to mannose glycan. Nat Immunol. 2024;25(9):1692–703.
CAS PubMed PubMed Central Google Scholar
Alter G, Ottenhoff THM, Joosten SA. Antibody glycosylation in inflammation, disease and vaccination. Semin Immunol. 2018;39:102–10.
CAS PubMed PubMed Central Google Scholar
Huang C, Liu Y, Wu H, Sun D, Li Y. Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis. Anal Bioanal Chem. 2017;409(15):3731–9.
McQuiston A, Scott D, Nord D, Langerude L, Pelaez A, Machuca T, Mehta A, Drake RR, Christie JD, Angel P, Atkinson C. Pro-inflammatory IgG1 N-glycan signature correlates with primary graft dysfunction onset in COPD patients. Transpl Immunol. 2022;71:101491.
Powers TW, Holst S, Wuhrer M, Mehta AS, Drake RR. Two-dimensional N-glycan distribution mapping of hepatocellular carcinoma tissues by MALDI-imaging mass spectrometry. Biomolecules. 2015;5(4):2554–2572.
Briggs MT, Condina MR, Ho YY, Everest-Dass AV, Mittal P, Kaur G, Oehler MK, Packer NH, Hoffmann P. MALDI mass spectrometry imaging of early- and late-stage serous ovarian cancer tissue reveals stage-specific N-glycans. Proteomics. 2019;19(21–22):1800482.
Drake RR, Powers TW, Jones EE, Bruner E, Mehta AS, Angel PM. MALDI mass spectrometry imaging of N-linked glycans in cancer tissues. Adv Cancer Res. 2017;134:85–116.
Drake RR, McDowell C, West C, David F, Powers TW, Nowling T, Bruner E, Mehta AS, Angel PM, Marlow LA, Tun HW, Copland JA. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry. J Mass Spectrom. 2020;55(4):e4490.
CAS PubMed PubMed Central Google Scholar
Hu Y, Mechref Y. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis. 2012;33(12):1768–77.
CAS PubMed PubMed Central Google Scholar
Drake RR, Powers TW, Norris-Caneda K, Mehta AS, Angel PM. In situ imaging of N-glycans by MALDI imaging mass spectrometry of fresh or formalin-fixed paraffin-embedded tissue. Curr Protoc Protein Sci. 2018;94(1):e68.
Drake RR, West CA, Mehta AS, Angel PM. MALDI mass spectrometry imaging of N-linked glycans in tissues. Adv Exp Med Biol. 2018;1104:59–76.
Black AP, Liang H, West CA, Wang M, Herrera HP, Haab BB, Angel PM, Drake RR, Mehta AS. A novel mass spectrometry platform for multiplexed N-glycoprotein biomarker discovery from patient biofluids by antibody panel based N-glycan imaging. Anal Chem. 2019;91(13):8429–35.
CAS PubMed PubMed Central Google Scholar
Scott DA, Wang M, Grauzam S, Pippin S, Black A, Angel PM, Drake RR, Castellino S, Kono Y, Rockey DC, Mehta AS. GlycoFibroTyper: a novel method for the glycan analysis of IgG and the development of a biomarker signature of liver fibrosis. Front Immunol. 2022;13:797460.
Dressman JW, McDowell CT, Lu X, Angel PM, Drake RR, Mehta AS. Development of an antibody-based platform for the analysis of immune cell-specific N-linked glycosylation. Anal Chem. 2023;95(27):10289–97.
CAS PubMed PubMed Central Google Scholar
Maley F, Trimble RB, Tarentino AL, Plummer TH. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem. 1989;180(2):195–204.
de Haan N, Reiding KR, Krištić J, Hipgrave Ederveen AL, Lauc G, Wuhrer M. The N-glycosylation of mouse immunoglobulin G (IgG)-fragment crystallizable differs between IgG subclasses and strains. Front Immunol. 2017;8:608.
PubMed PubMed Central Google Scholar
Wang W, Maliepaard JCL, Damelang T, Vidarsson G, Heck AJR, Reiding KR. Human IgG subclasses differ in the structural elements of their N-glycosylation. ACS Cent Sci. 2024;10(11):2048–58.
CAS PubMed PubMed Central Google Scholar
Raju TS, Briggs JB, Borge SM, Jones AJS. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology. 2000;10(5):477–86.
Urban J, Afseth NK, Štys D. Fundamental definitions and confusions in mass spectrometry about mass assignment, centroiding and resolution. TrAC, Trends Anal Chem. 2014;53:126–36.
Liu S, Liu X., Chapter One - IgG N-glycans. In: Makowski GS, editor. Adv Clin Chem: Elsevier; 2021;105:1–47.
Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res. 2008;7(4):1650–9.
Bucknall M, Fung KY, Duncan MW. Practical quantitative biomedical applications of MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom. 2002;13(9):1015–27.
Tobias F, Hummon AB. Considerations for MALDI-based quantitative mass spectrometry imaging studies. J Proteome Res. 2020;19(9):3620–30.
CAS PubMed PubMed Central Google Scholar
Sarvas HO, Seppälä IJT, Tähtinen T, Péterfy F, Mäkelä O. Mouse IgG antibodies have subclass associated affinity differences. Mol Immunol. 1983;20(3):239–46.
Gabriel CL, Smith PB, Mendez-Fernandez YV, Wilhelm AJ, Ye AM, Major AS. Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus. Am J Physiol Endocrinol Metab. 2012;303(11):E1313–24.
CAS PubMed PubMed Central Google Scholar
Sáez Moya M, Gutiérrez-Cózar R, Puñet-Ortiz J, Rodríguez de la Concepción ML, Blanco J, Carrillo J, Engel P. Autoimmune B cell repertoire in a mouse model of Sjögren’s syndrome. Front Immunol. 2021;12:666545.
PubMed PubMed Central Google Scholar
Sakthiswary R, Shaharir SS, Wahab AA. Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review. Biomedicines. 2022;10:(3).
Rana RS, Naik B, Yadav M, Singh U, Singh A, Singh S. Serum complements and immunoglobulin profiles in systemic lupus erythematosus patients: an observational study at a teaching hospital. J Family Med Prim Care. 2022;11(2):608–13.
PubMed PubMed Central Google Scholar
Zhang H, Li P, Wu D, Xu D, Hou Y, Wang Q, Li M, Li Y, Zeng X, Zhang F, Shi Q. Serum IgG subclasses in autoimmune diseases. Medicine (Baltimore). 2015;94(2):e387.
Ye C, Chen W, Gao Q, Chen Y, Song X, Zheng S, Liu J. Secondary immunodeficiency and hypogammaglobulinemia with IgG levels of <5 g/L in patients with multiple myeloma: a retrospective study between 2012 and 2020 at a university hospital in China. Med Sci Monit. 2021;27:e930241.
CAS PubMed PubMed Central Google Scholar
Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007;99(3):281–3.
PubMed PubMed Central Google Scholar
Spaner DE, Venema R, Huang J, Norris P, Lazarus A, Wang G, Shi Y. Association of blood IgG with tumor necrosis factor-alpha and
Comments (0)